4D Molecular Therapeutics, Inc. (FDMT)
12.18
+0.23
(+1.92%)
USD |
NASDAQ |
Nov 04, 13:21
4D Molecular Therapeutics Price : 12.18 for Nov. 4, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 03, 2026 | 11.52 | 12.08 | 11.46 | 11.95 | 740405.0 |
| Nov 02, 2026 | 11.88 | 12.06 | 11.16 | 11.37 | 734784.0 |
| Oct 30, 2026 | 12.49 | 12.88 | 11.74 | 11.90 | 683494.0 |
| Oct 29, 2026 | 13.00 | 13.46 | 12.57 | 12.78 | 848927.0 |
| Oct 28, 2026 | 11.89 | 12.96 | 11.73 | 12.93 | 1.190M |
| Oct 27, 2026 | 10.96 | 11.99 | 10.75 | 11.96 | 1.135M |
| Oct 26, 2026 | 10.74 | 11.29 | 10.62 | 11.03 | 1.085M |
| Oct 23, 2026 | 11.74 | 11.75 | 10.68 | 10.80 | 996140.0 |
| Oct 22, 2026 | 12.60 | 13.12 | 11.68 | 11.85 | 1.355M |
| Oct 21, 2026 | 13.12 | 13.45 | 12.60 | 12.62 | 2.019M |
| Oct 20, 2026 | 12.29 | 13.39 | 12.29 | 13.10 | 725372.0 |
| Oct 19, 2026 | 12.36 | 12.68 | 12.21 | 12.29 | 855680.0 |
| Oct 16, 2026 | 12.84 | 12.84 | 12.00 | 12.14 | 794535.0 |
| Oct 15, 2026 | 12.30 | 13.01 | 12.04 | 12.87 | 787614.0 |
| Oct 14, 2026 | 12.18 | 12.58 | 11.99 | 12.20 | 632964.0 |
| Oct 13, 2026 | 12.91 | 12.91 | 12.25 | 12.36 | 991721.0 |
| Oct 12, 2026 | 13.30 | 13.47 | 12.86 | 13.00 | 835835.0 |
| Oct 09, 2026 | 12.70 | 13.85 | 12.55 | 13.33 | 868094.0 |
| Oct 08, 2026 | 12.42 | 12.74 | 12.12 | 12.70 | 970765.0 |
| Oct 07, 2026 | 12.36 | 12.92 | 12.18 | 12.59 | 603568.0 |
| Oct 06, 2026 | 12.64 | 13.02 | 12.30 | 12.56 | 1.171M |
| Oct 05, 2026 | 13.86 | 13.86 | 12.61 | 12.92 | 2.111M |
| Oct 02, 2026 | 14.12 | 14.14 | 13.60 | 13.67 | 1.037M |
| Oct 01, 2026 | 14.23 | 14.58 | 13.80 | 13.84 | 655464.0 |
| Sep 30, 2026 | 14.76 | 14.83 | 14.08 | 14.31 | 1.037M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 6.97 |
| Amgen, Inc. | 478.61 |
| Anika Therapeutics, Inc. | 20.34 |
| BioCryst Pharmaceuticals, Inc. | 8.51 |
| Imunon, Inc. | 0.9157 |
Price Related Metrics
| PS Ratio | 8.342 |
| Price to Book Value | 1.650 |
| Earnings Yield | -22.37% |
| Market Cap | 672.51M |